Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth [Yahoo! Finance]
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Morgan Stanley from $495.00 to $408.00. They now have an "equal weight" rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at HC Wainwright from $570.00 to $510.00. They now have a "buy" rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $529.00 to $462.00. They now have a "buy" rating on the stock.